FF
AZN icon

Friedenthal Financial’s AstraZeneca AZN Stock Holding History

Friedenthal Financial’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-51
Closed -$7.75K – 260
2025
Q3 		$7.75K Hold
51
– – ﹤0.01% 200
2025
Q2 		$7.06K Hold
51
– – ﹤0.01% 198
2025
Q1 		$7.42K Hold
51
– – ﹤0.01% 182
2024
Q4 		$6.62K Hold
51
– – ﹤0.01% 215
2024
Q3 		$7.87K Hold
51
– – ﹤0.01% 200
2024
Q2 		$7.88K Hold
51
– – ﹤0.01% 198
2024
Q1 		$6.84K Hold
51
– – ﹤0.01% 199
2023
Q4 		$6.8K Buy
+51
New +$6.63K ﹤0.01% 202

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Friedenthal Financial's AZN Position: Q4 2025 in Review

Friedenthal Financial sold out of AstraZeneca (AZN) in Q4 2025, closing a stake of 51 shares — an estimated $7.75K sold.

Friedenthal Financial first reported a position in AZN in Q4 2023 and held it in 8 quarters. The position peaked at $7.88K in Q2 2024. 1,407 funds tracked by Wall St. Rank hold AZN as of Q4 2025.

  • Friedenthal Financial reported no remaining AstraZeneca position as of Q4 2025 after selling out during the quarter.
  • Friedenthal Financial sold 51 AstraZeneca shares in Q4 2025, an estimated $7.75K.
  • Friedenthal Financial first reported a position in AstraZeneca in Q4 2023 and held it in 8 quarters.
  • Friedenthal Financial's AstraZeneca position peaked at $7.88K in Q2 2024.
  • 1,407 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2025.

Based on Friedenthal Financial's 13F filing for Q4 2025, filed 27 Jan 2026.